Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):473-80

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA CARDIOANGIOLOGICA

Rivista sulle Malattie del Cuore e dei Vasi


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY


Minerva Cardioangiologica 2016 August;64(4):473-80

lingua: Inglese

Overview of the clinical trials on bioresorbable vascular scaffold

Angela FERRARA 1, Giuseppe DI GIOIA 2, Teresa STRISCIUGLIO 2, William WIJNS 1, Emanuele BARBATO 1, 2

1 Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium; 2 Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy


PDF  


Although several new scaffolds are progressively being investigated and entering the clinical scene, BRS has accumulated the largest experience by far including detailed evaluation of the first patients studied followed almost in parallel by clinical evaluation and worldwide randomized evaluation for non-inferiority against best contemporary metallic DES. Available evidence shows that careful procedural technique is required for proper and safe delivery of the current generation scaffolds. Future studies will indicate whether all or only selected patient or lesion subsets will ultimately benefit from treatment with fully bioresorbable devices.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

emanuele.barbato@olvz-aalst.be